Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms

Neuroscience and Biobehavioral Reviews

Volumn 74, Issue , 2017, Pages 277-286

  Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac autonomic control; Cardiovascular; Cortisol; Depression; Epidemiology; Inflammation; Lifestyle; Metabolic syndrome

Indexed keywords

ACUTE STRESS; ALCOHOLISM; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IATROGENIC DISEASE; IMMUNE DYSREGULATION; INFLAMMATION; LIFESTYLE; LONGITUDINAL STUDY; MAJOR DEPRESSION; METABOLIC DISORDER; PATHOPHYSIOLOGY; PHYSICAL INACTIVITY; REVIEW; SMOKING; TREATMENT REFUSAL; UNHEALTHY DIET; ANXIETY; DEPRESSION; QUALITY OF LIFE;

ANXIETY; CARDIOVASCULAR DISEASES; DEPRESSION; HUMANS; QUALITY OF LIFE;

EID: 84997107071     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.07.003     Document Type: Review

References (101)

1. Alexopoulos, G.S., The vascular depression hypothesis: 10 years later. Biol. Psychiatry 60 (2006), 1304–1305.
2. Anda, R.F., Williamson, D.F., Escobedo, L.G., Mast, E.E., Giovino, G.A., Remington, P.L., Depression and the dynamics of smoking. A national perspective. JAMA 264 (1990), 1541–1545.
3. Bartels, M., de Moor, M.h.m., van der Aa, N., Boomsma, D.I., de Geus, E.J.C., Regular exercise, subjective wellbeing, and internalizing problems in adolescence: causality or genetic pleiotropy?. Front. Genet., 3, 2012, 4.
4. Batelaan, N., Seldenrijk, A., Bot, M., van Balkom, A., Penninx, B.W., Anxiety and new-onset of cardiovascular disease: a critical review and meta-analysis. Br. J. Psychiatry 208 (2016), 223–231.
5. Bomhof-Roordink, H., Seldenrijk, A., van Hout, H.p.j., van Marwijk, H.w.j., Diamant, M., Penninx, B.W.J.H., Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms. J. Psychosom. Res. 78 (2015), 332–339.
6. Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., Maes, M., Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 22 (2002), 86–90.
7. Bradley, S.M., Rumsfeld, J.S., Depression and cardiovascular disease. Trends Cardiovasc. Med. 25 (2015), 614–622.
8. Cesari, M., Penninx, B.w.j.h., Newman, A.B., Kritchevsky, S.B., Nicklas, B.J., Sutton-Tyrrell, K., Rubin, S.M., Ding, J., Simonsick, E.M., Harris, T.B., Pahor, M., Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003), 2317–2322.
9. Cherbuin, N., Kim, S., Anstey, K.J., Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open, 5, 2015, e008853.
10. Chida, Y., Hamer, M., Wardle, J., Steptoe, A., Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat. Clin. Pract. Oncol. 5 (2008), 466–475.
11. Cohen, B.E., Edmondson, D., Kronish, I.M., Depression, stress, anxiety and cardiovascular disease. Am. J. Hypertens. 28 (2015), 1295–1302.
12. Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., Penninx, B.W., Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am. J. Psychiatry 171 (2014), 453–462.
13. de Geus, E.J.C., Genetic pleiotropy in depression and coronary artery disease. Psychosom. Med. 68 (2006), 185–186.
14. de Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 (2005), 463–475.
15. de Moor, M.h.m., Boomsma, D.I., Stubbe, J.H., Willemsen, G., de Geus, E.J.C., Testing causality in the association between regular exercise and symptoms of anxiety and depression. Arch. Gen. Psychiatry 65 (2008), 897–905.
16. Dekker, J.M., Crow, R.S., Folsom, A.R., Hannan, P.J., Liao, D., Swenne, C.A., Schouten, E.G., Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC study. Atherosclerosis risk in communities. Circulation 102 (2000), 1239–1244.
17. DiMatteo, M.R., Lepper, H.S., Croghan, T.W., Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160 (2000), 2101–2107.
18. Dong, J.Y., Zhang, Y.H., Tong, J., Qin, L.Q., Depression and risk of stroke: a meta-analysis of prospective studies. Stroke 43 (2012), 32–37.
19. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67 (2010), 446–457.
20. Doyle, F., McGee, H., Conroy, R., Conradi, H.J., Meijer, A., Steeds, R., Sato, H., Stewart, D.E., Parakh, K., Carney, R., Freedland, K., Anselmino, M., Pelletier, R., Bos, E.H., de Jonge, P., Systematic review and individual patient data meta-analysis of sex differences in depression and prognosis in persons with myocardial infarction: a MINDMAPS study. Psychosom. Med. 77 (2015), 419–428.
21. Druss, B.G., Bradford, W.D., Rosenheck, R.A., Radford, M.J., Krumholz, H.M., Quality of medical care and excess mortality in older patients with mental disorders. Arch. Gen. Psychiatry 58 (2001), 565–572.
22. Eyre, H.A., Lavretsky, H., Kartika, J., Qassim, A., Baune, B.T., Modulatory effects of antidepressant classes on the innate and adaptive immune system in depression. Pharmacopsychiatry 49 (2016), 85–96.
23. Girshkin, L., Matheson, S.L., Shepherd, A.M., Green, M.J., Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 49 (2014), 187–206.
24. Glassman, A.H., O'Connor, C.M., Califf, R.M., Swedberg, K., Bigger, J.t.j., Krishnan, K.r.r., Schwartz, P., van Zyl, L.T., Swenson, J.R., Finkel, M.S., Landau, C., Shapiro, P.A., Pepine, C.J., Mardekian, J., Harrison, W.M., Barton, D., Mclvor, M., Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002), 701–709.
25. Grande, G., Romppel, M., Barth, J., Association between type D personality and prognosis in patients with cardiovascular diseases: a systematic review and meta-analysis. Ann. Behav. Med. 43 (2012), 299–310.
26. Hamer, M., Steptoe, A., Cortisol responses to mental stress and incident hypertension in healthy men and women. J. Clin. Endocrinol. Metab. 97 (2012), E29–34.
27. Hamer, M., Kivimaki, M., Lahiri, A., Marmot, M.G., Steptoe, A., Persistent cognitive depressive symptoms are associated with coronary artery calcification. Atherosclerosis 210 (2010), 209–213.
28. Hamer, M., Batty, G.D., Seldenrijk, A., Kivimaki, M., Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur. Heart J. 32 (2011), 437–442.
29. Hannestad, J., DellaGioia, N., Bloch, M., The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36 (2011), 2452–2459.
30. Hinkelmann, K., Moritz, S., Botzenhardt, J., Muhtz, C., Wiedemann, K., Kellner, M., Otte, C., Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology 37 (2012), 685–692.
31. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71 (2009), 171–186.
32. Hu, M.X., Lamers, F., de Geus, E.J., Penninx, B.W., Differential autonomic nervous system reactivity in depression and anxiety during stress depending on type of stressor. Psychosom. Med., 2016.
33. Jokela, M., Pulkki-Raback, L., Elovainio, M., Kivimaki, M., Personality traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies. J. Behav. Med. 37 (2014), 881–889.
34. Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.G., Collins, R., Danesh, J., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375 (2010), 132–140.
35. Kemp, A.H., Quintana, D.S., Gray, M.A., Felmingham, K.L., Brown, K., Gatt, J.M., Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol. Psychiatry 67 (2010), 1067–1074.
36. Kemp, A.H., Brunoni, A.R., Santos, I.S., Nunes, M.A., Dantas, E.M., Carvalho de Figueiredo, R., Pereira, A.C., Ribeiro, A.l.p., Mill, J.G., Andreao, R.V., Thayer, J.F., Bensenor, I.M., Lotufo, P.A., Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am. J. Psychiatry 171 (2014), 1328–1334.
37. Knorr, U., Vinberg, M., Kessing, L.V., Wetterslev, J., Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 35 (2010), 1275–1286.
38. Kuehl, L.K., Hinkelmann, K., Muhtz, C., Dettenborn, L., Wingenfeld, K., Spitzer, C., Kirschbaum, C., Wiedemann, K., Otte, C., Hair cortisol and cortisol awakening response are associated with criteria of the metabolic syndrome in opposite directions. Psychoneuroendocrinology 51 (2015), 365–370.
39. Kumari, M., Shipley, M., Stafford, M., Kivimaki, M., Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J. Clin. Endocrinol. Metab. 96 (2011), 1478–1485.
40. Lamers, F., de Jonge, P., Nolen, W.A., Smit, J.H., Zitman, F.G., Beekman, A.t.f., Penninx, B.W.J.H., Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). J. Clin. Psychiatry 71 (2010), 1582–1589.
41. Lamers, F., Rhebergen, D., Merikangas, K.R., de Jonge, P., Beekman, A.t.f., Penninx, B.W.J.H., Stability and transitions of depressive subtypes over a 2-year follow-up. Psychol. Med. 42 (2012), 2083–2093.
42. Lamers, F., Burstein, M., He, J.P., Avenevoli, S., Angst, J., Merikangas, Structure of major depressive disorder in adolescents and adults in the US general population. Br. J. Psychiatry 201 (2012), 143–150.
43. Lamers, F., Vogelzangs, N., Merikangas, K.R., de Jonge, P., Beekman, A.t.f., Penninx, B.W.J.H., Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18 (2013), 692–699.
44. Lamers, F., Beekman, A., van Hemert, A., Schoevers, R., Penninx, B., Six-year longitudinal course and outcomes of subtypes of depression. Br. J. Psychiatry 208 (2016), 62–68.
45. Lasserre, A.M., Glaus, J., Vandeleur, C.L., Marques-Vidal, P., Vaucher, J., Bastardot, F., Waeber, G., Vollenweider, P., Preisig, M., Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study. JAMA Psychiatry 71 (2014), 880–888.
46. Licht, C.M.M., de Geus, E.J.C., Zitman, F.G., Hoogendijk, W.J.G., van Dyck, R., Penninx, B.W.J.H.v., Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch. Gen. Psychiatry 65 (2008), 1358–1367.
47. Licht, C.m.m., de Geus, E.j.c., Seldenrijk, A., van Hout, H.p.j., Zitman, F.G., van Dyck, R., Penninx, B.W.J.H., Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53 (2009), 631–638.
48. Licht, C.M., Vreeburg, S.A., van Reedt Dortland, A.K., Giltay, E.J., Hoogendijk, W.J., DeRijk, R.H., Vogelzangs, N., Zitman, F.G., de Geus, E.J., Penninx, B.W., Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J. Clin. Endocrinol. Metab. 95 (2010), 2458–2466.
49. Licht, C.m.m., de Geus, E.j.c., Dyck, R., Penninx, B.W.J.H., Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol. Psychiatry 68 (2010), 861–868.
50. Licht, C.M., Penninx, B.W., de Geus, E.J., Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study. Neuropsychopharmacology. 37:11 (2012), 2487–2495.
51. Licht, C.m.m., de Geus, E.j.c., Penninx, B.W.J.H., Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J. Clin. Endocrinol. Metab. 98 (2013), 2484–2493.
52. Licht, C.m.m., Naarding, P., Penninx, B.w.j.h., van der Mast, R.C., de Geus, E.j.c., Comijs, H., The association between depressive disorder and cardiac autonomic control in adults 60 years and older. Psychosom. Med. 77 (2015), 279–291.
53. Liu, Y., Ho, R.c.-M., Mak, A., Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139 (2012), 230–239.
54. Luppino, F.S., de Wit, L.M., Bouvy, P.F., Stijnen, T., Cuijpers, P., Penninx, B.W., Zitman, F.G., Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 67 (2010), 220–229.
55. Meng, L., Chen, D., Yang, Y., Zheng, Y., Hui, R., Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. J. Hypertens. 30 (2012), 842–851.
56. Mezuk, B., Eaton, W.W., Albrecht, S., Golden, S.H., Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31 (2008), 2383–2390.
57. Milaneschi, Y., Hoogendijk, W., Lips, P., Heijboer, A.C., Schoevers, R., van Hemert, A.M., Beekman, A.t.f., Smit, J.H., Penninx, B.W.J.H., The association between low vitamin D and depressive disorders. Mol. Psychiatry 19 (2014), 444–451.
58. Milaneschi, Y., Lamers, F., Peyrot, W., Abdellaoui, A., Willemsen, G., Hottenga, J., Jansen, R., Mbarek, H., Dehghan, A., Lu, C., Boomsma, D., Penninx, B., Polygenic dissection of major depression clinical heterogeneity. Mol. Psychiatry 21 (2016), 516–522.
59. Milaneschi, Y., Lamers, F., Bot, M., Drent, M.L., Penninx, B.W., Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression. Biol. Psychiatry, 2016.
60. Mottillo, S., Filion, K.B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E.L., Eisenberg, M.J., The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 56 (2010), 1113–1132.
61. Mulle, J.G., Vaccarino, V., Cardiovascular disease, psychosocial factors, and genetics: the case of depression. Prog. Cardiovasc. Dis., 55, 2013 557–552.
62. Nelson, J.C., Davis, J.M., DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 154 (1997), 1497–1503.
63. Nicholson, A., Kuper, H., Hemingway, H., Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur. Heart J. 27 (2006), 2763–2774.
64. Noordam, R., van den Berg, M.E., Niemeijer, M.N., Aarts, N., Hofman, A., Tiemeier, H., Kors, J.A., Stricker, B.H., Eijgelsheim, M., Visser, L.E., Rijnbeek, P.R., Antidepressants and heart-rate variability in older adults: a population-based study. Psychol. Med. 46 (2016), 1239–1247.
65. Pan, A., Keum, N., Okereke, O.I., Sun, Q., Kivimaki, M., Rubin, R.R., Hu, F.B., Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35 (2012), 1171–1180.
66. Paz-Filho, G., Wong, M.L., Licinio, J., The procognitive effects of leptin in the brain and their clinical implications. Int. J. Clin. Pract. 64 (2010), 1808–1812.
67. Penninx, B.W., van Tilburg, T., Boeke, A.J., Deeg, D.J., Kriegsman, D.M., van Eijk, J.T., Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases?. Health Psychol. 5 (1998), 1–558.
68. Penninx, B.W., Guralnik, J.M., Ferrucci, L., Fried, L.P., Allen, R.H., Stabler, S.P., Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am. J. Psychiatry 157 (2000), 715–721.
69. Penninx, B.w.j.h., Beekman, A.t.f., Smit, J.H., Zitman, F.G., Nolen, W.A., Spinhoven, P., Cuijpers, P., De Jong, P.J., van Marwijk, H.w.j., Assendelft, W.j.j., Van Der Meer, K., Verhaak, P., Wensing, M., De Graaf, R., Hoogendijk, W.J., Ormel, J., van Dyck, R., The netherlands study of depression and anxiety (NESDA): rationale, objectives and methods. Int. J. Methods Psychiatry Res. 17 (2008), 121–140.
70. Penninx, B.w.j.h., Milaneschi, Y., Lamers, F., Vogelzangs, N., Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med., 11, 2013, 129.
71. Porges, S.W., The polyvagal theory: phylogenetic substrates of a social nervous system. Int. J. Psychophysiol. 42 (2001), 123–146.
72. Rottenberg, J., Chambers, A.S., Allen, J.j.b., Manber, R., Cardiac vagal control in the severity and course of depression: the importance of symptomatic heterogeneity. J. Affect. Disord. 103 (2007), 173–179.
73. Sanhueza, C., Ryan, L., Foxcroft, D.R., Diet and the risk of unipolar depression in adults: systematic review of cohort studies. J. Hum. Nutr. Diet. 26 (2013), 56–70.
74. Scott, K.M., de Jonge, P., Alonso, J., Viana, M.C., Liu, Z., O'Neill, S., Aguilar-Gaxiola, S., Bruffaerts, R., Caldas-de-Almeida, J.M., Stein, D.J., de Girolamo, G., Florescu, S.E., Hu, C., Taib, N.I., Lepine, J.P., Levinson, D., Matschinger, H., Medina-Mora, M.E., Piazza, M., Posada-Villa, J.A., Uda, H., Wojtyniak, B.J., Lim Ccw Kessler, R.C., Associations between DSM-IV mental disorders and subsequent heart disease onset: beyond depression. Int. J. Cardiol. 168 (2013), 5293–5299.
75. Seldenrijk, A., Vogelzangs, N., van Hout, H.p.j., van Marwijk, H.w.j., Diamant, M., Penninx, B.W.J.H., Depressive and anxiety disorders and risk of subclinical atherosclerosis Findings from the Netherlands Study of Depression and Anxiety (NESDA). J. Psychosom. Res. 69 (2010), 203–210.
76. Seldenrijk, A., van Hout, H.p.j., van Marwijk, H.w.j., de Groot, E., Gort, J., Rustemeijer, C., Diamant, M., Penninx, B.W.J.H., Depression, anxiety, and arterial stiffness. Biol. Psychiatry 69 (2011), 795–803.
77. Shelton, R.C., Miller, A.H., Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog. Neurobiol. 91 (2010), 275–299.
78. Silverman, M.N., Sternberg, E.M., Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. N. Y. Acad. Sci. 1261 (2012), 55–63.
79. Stephens, T., Physical activity and mental health in the United States and Canada: evidence from four population surveys. Prev. Med. 17 (1988), 35–47.
80. Stetler, C., Miller, G.E., Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73 (2011), 114–126.
81. Sublette, M.E., Postolache, T.T., Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosom. Med. 74 (2012), 668–672.
82. Sullivan, P.F., Kessler, R.C., Kendler, K.S., Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. Am. J. Psychiatry 155 (1998), 1398–1406.
83. Sullivan, P.F., Prescott, C.A., Kendler, K.S., The subtypes of major depression in a twin registry. J. Affect. Disord. 68 (2002), 273–284.
84. Sumner, J.A., Kubzansky, L.D., Elkind, M.s.v., Roberts, A.L., Agnew-Blais, J., Chen, Q., Cerda, M., Rexrode, K.M., Rich-Edwards, J.W., Spiegelman, D., Suglia, S.F., Rimm, E.B., Koenen, K.C., Trauma exposure and posttraumatic stress disorder symptoms predict onset of cardiovascular events in women. Circulation 132 (2015), 251–259.
85. Taylor, C.B., Youngblood, M.E., Catellier, D., Veith, R.C., Carney, R.M., Burg, M.M., Kaufmann, P.G., Shuster, J., Mellman, T., Blumenthal, J.A., Krishnan, R., Jaffe, A.S., Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 62 (2005), 792–798.
86. Teicher, M.H., Samson, J.A., Childhood maltreatment and psychopathology: a case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am. J. Psychiatry 170 (2013), 1114–1133.
87. Tsuji, H., Larson, M.G., Venditti, F.j.j., Manders, E.S., Evans, J.C., Feldman, C.L., Levy, D., Impact of reduced heart rate variability on risk for cardiac events. The framingham heart study. Circulation 94 (1996), 2850–2855.
88. Van der Kooy, K., van Hout, H., Marwijk, H., Marten, H., Stehouwer, C., Beekman, A., Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry 22 (2007), 613–626.
89. van Melle, J.P., de Jonge, P., Honig, A., Schene, A.H., Kuyper, A.m.g., Crijns, H.j.g.m., Schins, A., Tulner, D., van den Berg, M.P., Ormel, J., Effects of antidepressant treatment following myocardial infarction. Br. J. Psychiatry, 2007, 460–466.
90. van Reedt Dortland, A.k.b., Giltay, E.J., van Veen, T., Zitman, F.G., Penninx, B.W.J.H., Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatry Scand. 122 (2010), 30–39.
91. van Reedt Dortland, A.K., Giltay, E.J., van Veen, T., Zitman, F.G., Penninx, B.W., Longitudinal relationship of depressive and anxiety symptoms with dyslipidemia and abdominal obesity. Psychosom Med. 75:1 (2013), 83–89.
92. van Zyl, L.T., Hasegawa, T., Nagata, K., Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc Med, 2, 2008, 12.
93. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H., Harris, T.B., Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999), 2131–2135.
94. Vogelzangs, N., Beekman, A.t.f., Milaneschi, Y., Bandinelli, S., Ferrucci, L., Penninx, B.W.J.H., Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J. Clin. Endocrinol. Metab. 95 (2010), 4959–4964.
95. Vogelzangs, N., Beekman, A.t.f., Boelhouwer, I.G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., Penninx, B.W.J.H., Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J. Clin. Psychiatry 72 (2011), 598–604.
96. Vogelzangs, N., Duivis, H.E., Beekman, A.t.f., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J.H., de Jonge, P., Penninx, B.W.J.H., Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry, 2, 2012, e79.
97. Vogelzangs, N., Beekman, A.t.f., van Reedt Dortland, A.k.b., Schoevers, R.A., Giltay, E.J., de Jonge, P., Penninx, B.W.J.H., Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 39 (2014), 1624–1634.
98. Vreeburg, S.A., Hoogendijk, W.j.g., van Pelt, J., Derijk, R.H., Verhagen, J.c.m., van Dyck, R., Smit, J.H., Zitman, F.G., Penninx, B.W.J.H., Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 66 (2009), 617–626.
99. Vreeburg, S.A., Hartman, C.A., Hoogendijk, W.j.g., van Dyck, R., Zitman, F.G., Ormel, J., Penninx, B.W.J.H., Parental history of depression or anxiety and the cortisol awakening response. Br. J. Psychiatry 197 (2010), 180–185.
100. Walker, E.R., McGee, R.E., Druss, B.G., Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72 (2015), 334–341.
101. Whang, W., Kubzansky, L.D., Kawachi, I., Rexrode, K.M., Kroenke, C.H., Glynn, R.J., Garan, H., Albert, C.M., Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J. Am. Coll. Cardiol. 53 (2009), 950–958.